Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 496121 - 496140 out of 498419 entries
Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
---|---|---|---|---|---|---|---|---|
USA | (L01EA03) nilotinib (adm: O) | NILOTINIB 71MG TAB,PACK,28 | 4x28 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | AzurityPharmaceuticals,Inc. |
USA | (L01EA03) nilotinib (adm: O) | NILOTINIB 71MG TAB,PACK,28 | 4x28 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | AzurityPharmaceuticals,Inc. |
USA | (L01EA03) nilotinib (adm: O) | NILOTINIB 95MG TAB,PACK,28 | 4x28 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | AzurityPharmaceuticals,Inc. |
USA | (L01EA03) nilotinib (adm: O) | NILOTINIB 95MG TAB,PACK,28 | 4x28 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | AzurityPharmaceuticals,Inc. |
USA | (L01EB01) gefitinib (adm: O) | IRESSA 250MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | ASTRAZENECAPHARMACEUTICALSLP |
USA | (L01EB01) gefitinib (adm: O) | IRESSA 250MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | ASTRAZENECAPHARMACEUTICALSLP |
USA | (L01EB04) osimertinib (adm: O) | TAGRISSO 40MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | ASTRAZENECAPHARMACEUTICALSLP |
USA | (L01EB04) osimertinib (adm: O) | TAGRISSO 40MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | ASTRAZENECAPHARMACEUTICALSLP |
USA | (L01EB04) osimertinib (adm: O) | TAGRISSO 80MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | ASTRAZENECAPHARMACEUTICALSLP |
USA | (L01EB04) osimertinib (adm: O) | TAGRISSO 80MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | ASTRAZENECAPHARMACEUTICALSLP |
USA | (L01EE04) selumetinib | KOSELUGO 10MG CAP | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Neurofibromatosis 1 | ASTRAZENECAPHARMACEUTICALSLP |
USA | (L01EE04) selumetinib | KOSELUGO 10MG CAP | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Neurofibromatosis 1 | ASTRAZENECAPHARMACEUTICALSLP |
USA | (L01EE04) selumetinib | KOSELUGO 10MG CAP | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Neurofibromatosis 1 | ASTRAZENECAPHARMACEUTICALSLP |
USA | (L01EE04) selumetinib | KOSELUGO 10MG CAP | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Neurofibromatosis 1 | ASTRAZENECAPHARMACEUTICALSLP |
USA | (L01EE04) selumetinib | KOSELUGO 25MG CAP | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Neurofibromatosis 1 | ASTRAZENECAPHARMACEUTICALSLP |
USA | (L01EE04) selumetinib | KOSELUGO 25MG CAP | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Neurofibromatosis 1 | ASTRAZENECAPHARMACEUTICALSLP |
USA | (L01EE04) selumetinib | KOSELUGO 25MG CAP | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Neurofibromatosis 1 | ASTRAZENECAPHARMACEUTICALSLP |
USA | (L01EE04) selumetinib | KOSELUGO 25MG CAP | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Neurofibromatosis 1 | ASTRAZENECAPHARMACEUTICALSLP |
USA | (L01EL02) acalabrutinib (adm: O) | CALQUENCE 100MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Lymphocytic, Chronic, B-Cell | ASTRAZENECAPHARMACEUTICALSLP |
USA | (L01EL02) acalabrutinib (adm: O) | CALQUENCE 100MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Lymphocytic, Chronic, B-Cell | ASTRAZENECAPHARMACEUTICALSLP |